Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Latest filing published 13 Mar 2025 for Rapport Therapeutics, Inc., €92k. Read the official filing
Filing timeline
BuySaleTroy A. Ignelzi
Insider track record
Disclosed buys
1
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Troy A. Ignelzi: trading record in brief
Troy A. Ignelzi (finance chief) discloses dealings in 2 companies, chiefly Karuna Therapeutics, Inc. and Rapport Therapeutics, Inc. Between 10 May 2021 and 12 March 2025, the trades on record add up to 18 filings.
Both buying and selling appear: 1 purchase worth €92k, against 1 sale worth €568k. Netting one side against the other leaves €476k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 share grant and 15 option exercises. Since January 2025: 1 purchase and no sales on the market.
The record was last updated on 13 March 2025 with an open-market purchase (€92k) in Rapport Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Troy A. Ignelzi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
9,900 shares@ US$10.10100.0% of flowCommon StockSEC:0000950170-25-038878:0
Canonical exit: 10 Jun 2025 (T+90)
1,500 shares@ US$9.200.7% of flowCommon StockSEC:0000950170-23-044413:0
9,000 shares@ US$9.204.3% of flowCommon StockSEC:0000950170-23-024286:0
6,000 shares@ US$9.202.9% of flowCommon StockSEC:0001593968-23-000345:0
8,650 shares0Common StockSEC:0001593968-23-000304:0
817 shares@ US$9.200.4% of flowCommon StockSEC:0001593968-23-000170:0
10,869 shares@ US$9.205.2% of flowCommon StockSEC:0001593968-22-001741:0
16,500 shares@ US$9.208.2% of flowCommon StockSEC:0001593968-22-001609:0
2,459 shares@ US$227.0531.6% of flowCommon StockSEC:0001593968-22-001490:0
16,500 shares@ US$9.208.3% of flowCommon StockSEC:0001593968-22-001335:0
3,500 shares@ US$9.204.3% of flowCommon StockSEC:0001593968-22-000886:0
1,500 shares@ US$9.201.8% of flowCommon StockSEC:0001593968-22-000496:0
5,869 shares@ US$9.203.3% of flowCommon StockSEC:0001593968-21-002566:0
13,500 shares@ US$9.207.3% of flowCommon StockSEC:0001593968-21-002380:0
7,000 shares@ US$9.203.7% of flowCommon StockSEC:0001593968-21-002107:0
5,000 shares@ US$9.202.7% of flowCommon StockSEC:0001593968-21-002003:0
2,248 shares@ US$9.201.2% of flowCommon StockSEC:0001593968-21-001633:0
7,000 shares@ US$9.203.6% of flowCommon StockSEC:0001593968-21-001292:0
18 of 18 declarations
